Journal of Molecular Structure, vol.1306, 2024 (SCI-Expanded)
In the current study, we designed three novel compounds by merging two valuable nitrogen-containing pharmacophores, namely dihydropyrimidine (DHPM) and azole, within a single molecule. To obtain the target molecules, azole-linked benzaldehydes were initially synthesized via nucleophilic aromatic substitution reaction between 4-fluorobenzaldehyde and pyrazole, imidazole, or 1,2,4-triazole. Afterward, Biginelli reaction was applied to yield azole-carrying DHPMs. Following structural confirmation, the obtained compounds were tested for their alpha (α)-glucosidase inhibitory and antimicrobial activities. According to the biological data, DHPM-P and DHPM-T showed strong inhibition values whereas DHPM-I failed to effectively inhibit the α-glucosidase enzyme. This situation was explained by molecular docking studies of all compounds into the binding site of alpha-glucosidase. The title compounds also presented moderate antibacterial and antifungal activities. Computational methods based on density functional tight binding (DFTB) and density functional theory (DFT) calculations, along with molecular dynamics (MD) simulations were used to analyze the reactive properties of the compounds. A combination of DFTB and DFT calculations was applied to obtain the lowest energy conformations of the molecules. Further computational analysis included calculations of local reactivity descriptors, such as molecular electrostatic potential and average local ionization energy, by applying DFT calculations. DFT calculations were also used to study intramolecular non-covalent interactions. MD simulations were employed to understand how the title molecules behave in water and to obtain their solubility parameters.